Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (211-220 of 321) with videos related to

Pageof 33
Sort By:
Neuro-Oncology Advances|September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastomaMohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in miceWalid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Cancer|March 17, 2020
Primary dural lymphomas: Clinical presentation, management, and outcomePhilipp Karschnia, Tracy T Batchelor, Justin T Jordan, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Journal of Oncology Practice|January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain MassIsabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Neuro-Oncology|November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse gliomaTejus A Bale, Justin T Jordan, Otto Rapalino, et al.
NMR in Biomedicine|October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 TBernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2019
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade gliomaShervin Tabrizi, Beow Y Yeap, Janet C Sherman, et al.
Pageof 33

Showing results (211-220 of 321) with videos related to

Sort By:
Pageof 33
Neuro-Oncology Advances|September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastomaMohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in miceWalid S Kamoun, Carsten D Ley, Christian T Farrar, et al.
Cancer|March 17, 2020
Primary dural lymphomas: Clinical presentation, management, and outcomePhilipp Karschnia, Tracy T Batchelor, Justin T Jordan, et al.
Neuro-Oncology Advances|January 4, 2021
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patientsElizabeth R Gerstner, Kyrre E Emblem, Yi-Fen Yen, et al.
Journal of Oncology Practice|January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain MassIsabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Blood|July 2, 2008
CNS Hodgkin lymphomaElizabeth R Gerstner, Lauren E Abrey, David Schiff, et al.
Neuro-Oncology|November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse gliomaTejus A Bale, Justin T Jordan, Otto Rapalino, et al.
NMR in Biomedicine|October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 TBernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2019
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade gliomaShervin Tabrizi, Beow Y Yeap, Janet C Sherman, et al.
Pageof 33